BeyondSpring Inc.: Material agreement
BeyondSpring announced an agreement to fund the China portion of its Phase 3 trial, received FDA Fast Track designation, and established an at-the-market share offering program.
Positive for the companyWhat happened
- BeyondSpring agreed to sell its subsidiary holding indirect interests in Chinese entity Bulin to Biolin Investment Limited.
The full interpretation is in the app
Why it matters, the key numbers from the document and what to watch next: the full interpretation of every report is part of Pro.
Read the full interpretation